PTG logo

Poltreg S.A. Stock Price

WSE:PTG Community·zł112.4m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

PTG Share Price Performance

zł24.80
-27.20 (-52.31%)
zł24.80
-27.20 (-52.31%)
Price zł24.80

PTG Community Narratives

There are no narratives available yet.

Snowflake Analysis

Excellent balance sheet with moderate risk.

5 Risks
1 Reward

Poltreg S.A. Key Details

zł250.0k

Revenue

zł5.9m

Cost of Revenue

-zł5.6m

Gross Profit

zł18.8m

Other Expenses

-zł24.4m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-5.23
-2,241.60%
-9,751.20%
0%
View Full Analysis

About PTG

Founded
2016
Employees
33
CEO
Piotr Trzonkowsk
WebsiteView website
poltreg.tech

Poltreg S.A., a biotechnology company, researches and develops therapies for autoimmune diseases. It engages in the development of therapies for the treatment of type 1 diabetes in children, as well as multiple sclerosis. The company was incorporated in 2016 and is based in Gdansk, Poland.

Recent PTG News & Updates

We're Hopeful That Poltreg (WSE:PTG) Will Use Its Cash Wisely

Sep 02
We're Hopeful That Poltreg (WSE:PTG) Will Use Its Cash Wisely

Recent updates

No updates